Healthcare provider profile · identity verified

Ricky Winburn, M.D.

Internal Medicine · BATON ROUGE, LA · NPI 1760800395

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	515	157
Amlodipine Besylate	Amlodipine Besylate	502	154
Pantoprazole Sodium	Pantoprazole Sodium	279	91
Losartan Potassium	Losartan Potassium	249	71
Levothyroxine Sodium	Levothyroxine Sodium	240	67
Ozempic	Semaglutide	211	38
Metformin Hcl Er	Metformin Hcl	181	57
Rosuvastatin Calcium	Rosuvastatin Calcium	172	55
Alprazolam	Alprazolam	152	33
Lisinopril	Lisinopril	149	51
Hydrochlorothiazide	Hydrochlorothiazide	142	49
Azelastine Hcl	Azelastine Hcl	129	89
Doxazosin Mesylate	Doxazosin Mesylate	126	36
Jardiance	Empagliflozin	124	30
Furosemide	Furosemide	118	36
Metoprolol Succinate	Metoprolol Succinate	107	36
Gabapentin	Gabapentin	99	36
Sertraline Hcl	Sertraline Hcl	95	29
Tamsulosin Hcl	Tamsulosin Hcl	94	33
Trazodone Hcl	Trazodone Hcl	90	24
Pravastatin Sodium	Pravastatin Sodium	87	26
Omeprazole	Omeprazole	86	30
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	81	33
Metformin Hcl	Metformin Hcl	80	22
Allopurinol	Allopurinol	78	26
Carvedilol	Carvedilol	76	26
Mounjaro	Tirzepatide	71	16
Duloxetine Hcl	Duloxetine Hcl	69	24
Montelukast Sodium	Montelukast Sodium	69	22
Ezetimibe	Ezetimibe	68	20
Mupirocin	Mupirocin	68	56
Albuterol Sulfate Hfa	Albuterol Sulfate	63	42
Meloxicam	Meloxicam	60	18
Valsartan	Valsartan	60	16
Olmesartan Medoxomil	Olmesartan Medoxomil	58	22
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	57	13
Potassium Chloride	Potassium Chloride	56	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	18
Citalopram Hbr	Citalopram Hydrobromide	54	16
Diclofenac Sodium	Diclofenac Sodium	54	32
Triamcinolone Acetonide	Triamcinolone Acetonide	54	32
Novolog Flexpen	Insulin Aspart	49	suppressed
Hydralazine Hcl	Hydralazine Hcl	46	12
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	44	16
Pregabalin	Pregabalin	44	13
Ipratropium Bromide	Ipratropium Bromide	43	22
Bupropion Xl	Bupropion Hcl	41	13
Simvastatin	Simvastatin	40	15
Methocarbamol	Methocarbamol	39	28
Metoprolol Tartrate	Metoprolol Tartrate	39	13
Mirtazapine	Mirtazapine	39	16
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	38	22
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	37	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	36	14
Ondansetron Odt	Ondansetron	36	20
Donepezil Hcl	Donepezil Hcl	35	suppressed
Famotidine	Famotidine	35	12
Nifedipine Er	Nifedipine	35	suppressed
Prednisone	Prednisone	35	30
Azithromycin	Azithromycin	34	32
Fluticasone Propionate	Fluticasone Propionate	34	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Tramadol Hcl	Tramadol Hcl	34	13
Alendronate Sodium	Alendronate Sodium	33	11
Clopidogrel	Clopidogrel Bisulfate	33	12
Memantine Hcl	Memantine Hcl	32	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Glimepiride	Glimepiride	31	suppressed
Repatha Sureclick	Evolocumab	31	suppressed
Clonazepam	Clonazepam	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	26
Eliquis	Apixaban	30	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	21
Ketoconazole	Ketoconazole	29	15
Celecoxib	Celecoxib	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Colchicine	Colchicine	22	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Glipizide	Glipizide	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Linzess	Linaclotide	20	11
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	19	suppressed
Atenolol	Atenolol	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Cefdinir	Cefdinir	15	13
Dropsafe Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Ciclopirox	Ciclopirox	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Methylprednisolone	Methylprednisolone	14	13
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Lidocaine	Lidocaine	12	11
Lorazepam	Lorazepam	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Fluconazole	Fluconazole	11	11
Propranolol Hcl	Propranolol Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error